Cardiac Operation and End-Stage Renal Disease

Monson, Bjorn K.; Wickstrom, Per H.; Haglin, John J.; Francis, Gary S.; Comty, Christina M.; Helseth, Hovald K.

doi:10.1016/s0003-4975(10)61255-6

Cited by 37 publications

(7 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was wide variation in the results of some studies. [13][14][15][16][17][18][19][20][21][22][23][24] The reason for this was that the patient profiles, preoperative status, comorbid diseases, operation performed, and definition of terms were not uniformly compared. Whether or not any of these strategies improve outcome is impossible to say.…”

Section: Discussionmentioning

confidence: 99%

Coronary Artery Bypass Grafting in Patients with Chronic Renal Failure:A Reappraisal

et al. 1996

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Coronary Artery Bypass Grafting in Patients with Chronic Renal Failure:A Reappraisal

et al. 1996

View full text Add to dashboard Cite

show abstract

“…Coronary artery bypass grafting (CABG) for a patient with end‐stage renal disease (ESRD) was first reported in 1974 (1). Since then, numerous case reports and series of results have been published (2–31)(Appendix 1). In 1988, Opsahl et al reported that CABG effectively decreased cardiac related deaths in ESRD patients with significant coronary stenosis (24).…”

Section: Previously Reported Results Of Coronary Artery Bypass (Cabg)mentioning

confidence: 99%

“…However, the mortality and the morbidity of CABG for patients on chronic hemodialysis were still high, and the remote survival was disappointing (2–6). These surgical results may include valvular surgery, which may modify the patient's prognosis (2,4,6,12,15,17,19,20,22,24,26,28,30,31). To eliminate the effects of valvular disease, a retrospective study was carried out for the patients who underwent isolated CABG, and the perioperative and late outcome of the patients with ESRD on hemodialysis was collected and compared to those of the control patients.…”

Section: Previously Reported Results Of Coronary Artery Bypass (Cabg)mentioning

confidence: 99%

Coronary Artery Bypass Grafting for Hemodialysis‐ Dependent Patients

et al. 2001

View full text Add to dashboard Cite

Patients with end-stage renal disease carry a risk of coronary atherosclerosis. This study was performed to evaluate the perioperative and remote data of coronary artery bypass grafting (CABG) in hemodialysis dependent patients. We retrospectively analyzed the results of isolated CABG performed at Shin-Tokyo Hospital between June 1, 1993 and May 31, 2000. Preoperative, perioperative, and follow-up data of the patients on hemodialysis (Group HD, n = 37) were collected and compared with those of control patients (Group C, n = 1,639). Group HD consisted of 26 males and 11 females with a mean age of 59.9 +/- 8.1 years, and the mean number of bypasses was 2.5 +/- 1.1. Group HD had a longer postoperative intubation time, ICU stay, and hospital stay than Group C. The postoperative major complication rate in Group HD (18.9%) was not significantly different from that in Group C (11.3%). However, the inhospital mortality rate in Group HD (5.4%) was higher than Group C (0.6%). At the mean follow-up of 2.4 years, the actuarial 3-year survival of Groups HD and C were 90.6% and 97.6%, respectively (p < 0.001), excluding hospital mortality. The actuarial 3-year cardiac event-free rates were 84.3% in Group HD and 88.8% in Group C, showing no difference. Patients on chronic hemodialysis carry a significant risk of prolonged inhospital care and hospital death. Once successful surgical revascularization was completed, their long-term cardiac events could be controlled as effectively. The increased distant death rates was probably associated with the nature of renal disease.

show abstract

“…Chronic uremia, hypertension, hyperlipidemia and increased calcium phosphate product associated with secondary hyperparathyroidism predispose to cardiac valvular abnormalities in patients with chronic renal failure. Early studies on biologic valve implantation in these patients show accelerated calcification of bioprosthetic valves (Lamberti, 1978;Monson, 1980). Therefore, mechanical valves were recommended by the ACC/AHA in patient with chronic renal failure and the guideline considered the use of biologic valves potentially harmful.…”

Section: Comorbiditiesmentioning

confidence: 99%